Conversely, the level of expression of a small subset of four genes (MGRN1, PMEL, MLANA, and TYRP1) accurately predicted the outcome of patients with low-medium-grade MM and identified with high sensitivity the subgroup of these patients undergoing an aggressive disease. The gene discussed is PMEL; the disease is Miyoshi myopathy.